Our website uses cookies. Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and help us to understand how you use our site. Some cookies have been set. You can block and delete cookies, but parts of our site won’t work without them. By using our website, you accept our use of cookies. Find out more about cookies here.

Transforming the Way Coronary Artery Disease
is Diagnosed and Treated

The HeartFlow FFRCT Analysis is the first non-invasive diagnostic tool that aids clinicians in determining, vessel by vessel, both the extent of an artery’s narrowing and the impact that the narrowing has on blood flow to the heart.

By non-invasively identifying which patients do and do not need intervention, clinicians can reduce unnecessary invasive testing, reduce healthcare system costs and improve patient quality of life.

A number one with a background circle surrounding it

Improving the Health of Populations

A number two with a background circle surrounding it

Enhancing the Patient Experience

A number three with a background circle surrounding it


The text 'Reduces unnecessary invasive coronary angiograms (ICA)' (Reference 1) in a box, and a graphic of descending steps above
The text 'Helps direct patients to the most appropriate care' (Reference 1) in a box, and a graphic of a compass above
The text 'Provides a better patient experience' (Reference 3) in a box, and a graphic of a person with their arms upwards in a y-shape above
The text 'Reduces overall costs to the healthcare system' (References 2, 4) in a box, and the British Pound symbol above

NICE Guidance

About NICE: NICE is part of the UK Department of Health and provides national guidance and quality standards to improve health and social care throughout the UK. The organization publishes guidelines in several topical areas including the use of health technologies within the UK’s National Health Service (NHS) and clinical practice.

The National Institute for Health and Care Excellence (NICE) issued guidance on 13 February 2017 for the use of the HeartFlow® FFRCT Analysis to help determine the cause of stable chest pain in patients.

  • Based on the evidence, NICE concluded the technology is safe, has a high level of diagnostic accuracy, and may avoid the need for invasive coronary angiography.
  • NICE further concluded that, when compared to all other tests, use of the HeartFlow FFRCT Analysis could save the UK National Health Service approximately £214 per patient through avoiding unnecessary invasive tests and treatment.
  • This guidance follows the Chest Pain Guidelines (CG95) issued by NICE in November 2016, recommending non-invasive coronary CT angiography (cCTA) as the initial diagnostic test for patients with stable chest pain. NICE now recommends the HeartFlow FFRCT Analysis as the most cost effective option when additional information is needed by the clinician.

Contact Us

* Required fields

Sign Up for Updates

* Required fields


1 Douglas, et al. Eur Heart J. 2015.

2 Douglas, et al. J Am Coll Cardiol. 2016.

3 Hlatky, et al. J Am Coll Cardiol. 2015.

4 National Institute for Health and Care Excellence (2017). HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography. NICE medical technology guidance, February 2017. London: NICE.